Hyperfine reports Q1 EPS (12c), consensus (12c)

Reports Q1 revenue $2.14M, consensus $2.81M. “Our commercial efforts have primarily focused on the hospital business, where we’ve continued to experience longer and more variable sales cycles in the first quarter. During this time, we also made meaningful progress in expanding our pipeline, now including promising early opportunities in the neurology office setting. We’re enthusiastic about growing our presence across both hospitals and neurology offices, setting the stage for accelerated growth and a more diversified revenue profile beginning in the second half of 2025. Additionally, we expect upcoming FDA clearances to bring to market a new standard in image quality for portable brain MRI.” said Maria Sainz, Chief Executive Officer and President of Hyperfine (HYPR), Inc. “This first quarter was rich in progress related to our office business launch readiness and the technical work related to next gen Swoop system technology. I am very excited about the prospects for Hyperfine in the second half of 2025 and beyond.”